Addison Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Sell |
343
-16
| -4% | -$7.12K | 0.04% | 251 |
|
|
2025
Q1 | $174K | Buy |
359
+16
| +5% | +$7.76K | 0.05% | 226 |
|
|
2024
Q4 | $138K | Buy |
343
+11
| +3% | +$4.43K | 0.04% | 259 |
|
|
2024
Q3 | $154K | Buy |
332
+3
| +0.9% | +$1.4K | 0.04% | 252 |
|
|
2024
Q2 | $154K | Buy |
329
+17
| +5% | +$7.97K | 0.05% | 236 |
|
|
2024
Q1 | $130K | Hold |
312
| – | – | 0.04% | 257 |
|
|
2023
Q4 | $127K | Hold |
312
| – | – | 0.05% | 248 |
|
|
2023
Q3 | $108K | Buy |
312
+12
| +4% | +$4.17K | 0.05% | 241 |
|
|
2023
Q2 | $106K | Hold |
300
| – | – | 0.05% | 237 |
|
|
2023
Q1 | $94.5K | Sell |
300
-17
| -5% | -$5.36K | 0.05% | 233 |
|
|
2022
Q4 | $91.5K | Buy |
317
+2
| +0.6% | +$578 | 0.05% | 224 |
|
|
2022
Q3 | $91K | Hold |
315
| – | – | 0.06% | 199 |
|
|
2022
Q2 | $89K | Buy |
315
+2
| +0.6% | +$565 | 0.05% | 201 |
|
|
2022
Q1 | $82K | Hold |
313
| – | – | 0.04% | 228 |
|
|
2021
Q4 | $69K | Buy |
+313
| New | +$69K | 0.04% | 216 |
|